RESUMEN
Canine drug-resistant epilepsy is a prevailing issue in veterinary neurology. Alternative or additional treatment with cannabinoids is showing promising results in seizure management. A crucial component of the endocannabinoid system, cannabinoid receptor type 1 (CB1R), is heavily involved in the control of neurotransmitter release. Knowledge of its distribution in the epileptic brain would serve a better understanding of disease pathology and application of cannabinoids in dogs with epilepsy. CB1R distribution was assessed in sub-regions of hippocampus of dogs with idiopathic epilepsy, structural epilepsy and without cerebral pathology. In dogs with idiopathic epilepsy, significantly decreased CB1R expression compared to control animals was observed in CA1. In dogs with structural epilepsy, a significant increase in CB1R signal intensity in comparison to controls was observed. CB1R expression was higher in the structural group as compared to the idiopathic. Double immunofluorescence showed co-localization between CB1R and an astrocytic marker in about 50% of cells, regardless of the diagnosis. In summary, CB1R expression in canine hippocampus undergoes modification by the epileptic process and the direction of this change depends on the etiology of the disease. The distinct disease-associated CB1R expression needs to be considered in new treatment development for dogs with epilepsy.
Asunto(s)
Cannabinoides , Epilepsia , Perros , Animales , Epilepsia/veterinaria , Epilepsia/metabolismo , Convulsiones/metabolismo , Cannabinoides/metabolismo , Hipocampo/metabolismo , Receptores de Cannabinoides/metabolismoRESUMEN
In the mammalian brain, adult hippocampal neurogenesis (AHN) is suppressed by chronic stress, primarily at the ventral pole of the hippocampus. Based upon anatomy, we hypothesise that the caudal pole of the avian Hippocampal Formation (HF) presents a homologous subregion. We thus investigated whether AHN is preferentially suppressed in the caudal chicken HF by unpredictable chronic mild stress (UCMS). Adult hens were kept in control conditions or exposed to UCMS for 8 weeks. Hens experiencing UCMS had significantly fewer doublecortin-positive multipolar neurons (p < 0.001) and beaded axons (p = 0.021) at the caudal pole of the HF than controls. UCMS birds also had smaller spleens and lower baseline plasma corticosterone levels compared to controls. There were no differences in AHN at the rostral pole, nor were there differences in expression of genetic mediators of the HPA stress response in the pituitary or adrenal glands. Duration of tonic immobility and heterophil/lymphocyte (H/L) ratios were also not responsive to our UCMS treatment. These results support the hypothesised homology of the caudal pole of the avian HF to the ventral pole of the rodent hippocampus. Furthermore, quantifying neurogenesis in the caudal HF post-mortem may provide an objective, integrative measure of welfare in poultry, which may be more sensitive than current welfare measures.
Asunto(s)
Hipocampo/patología , Neuropéptidos/sangre , Estrés Psicológico/patología , Animales , Conducta Animal , Pollos , Modelos Animales de Enfermedad , Regulación de la Expresión Génica , Recuento de Linfocitos , Neurogénesis , Estrés Psicológico/sangre , Estrés Psicológico/genéticaRESUMEN
Multidrug resistance (MDR) is a kind of acquired resistance of microorganisms and cancer cells to chemotherapic drugs that are characterized by different chemical structure and different mechanism of action. Classic MDR is the consequence of the over-expression of a variety of proteins that extrude the chemotherapic from the cell, lowering its concentration below the effective one. The ABC (ATP Binding Cassette) is a ubiquitous and important family of such transporter proteins. Members of this super family are present in mammals as well as in prokaryotic organisms and use ATP as the energy source to activate the extrusion process. P-glycoprotein (Pgp) and Multidrug Resistance Proteins (MRP1 and sister proteins) are the most important and widely studied members of ABC super family. Our knowledge about the structures and functions of transporter proteins has definitely improved in recent years, following the resolution of the structure of bacterial pumps which opened the way to the building of homology models for the more complex Pgp and MRP. It can be anticipated that these results will have a strong impact on the design of more potent and safer MDR reverters. A huge number of small molecules, many of natural origin, are able to reverse multidrug resistance by inhibiting the functions of Pgp, MRP1 and sister proteins and their action has been considered a possible way to reverse MDR. However, while a few compounds have reached clinical trials, none of them has, so far, been cleared for therapeutic use. Two main reasons are at the base of this difficulty: i) MDR is a complex phenomenon that may arise from several different biochemical mechanisms, with the consequence that inhibition of transporter proteins may be insufficient to reverse it; ii) the physiological role of Pgp and sister proteins requires more potent modulators with proper selectivity and pharmacokinetic in order to avoid unwanted side effects. This paper first reviews the most recent discoveries on the structures and functions of the ABC super family, in particular Pgp and MRP. Then, the medicinal chemistry of MDR reverters, in light of these findings, is discussed and the molecules that are presently in development are reviewed.
Asunto(s)
Miembro 1 de la Subfamilia B de Casetes de Unión a ATP/antagonistas & inhibidores , Transportadoras de Casetes de Unión a ATP/fisiología , Resistencia a Múltiples Medicamentos/efectos de los fármacos , Moduladores del Transporte de Membrana/uso terapéutico , Proteínas Asociadas a Resistencia a Múltiples Medicamentos/antagonistas & inhibidores , Miembro 1 de la Subfamilia B de Casetes de Unión a ATP/química , Miembro 1 de la Subfamilia B de Casetes de Unión a ATP/fisiología , Transportadoras de Casetes de Unión a ATP/antagonistas & inhibidores , Transportadoras de Casetes de Unión a ATP/química , Ensayos Clínicos como Asunto , Diseño de Fármacos , Resistencia a Múltiples Medicamentos/fisiología , Humanos , Moduladores del Transporte de Membrana/química , Moduladores del Transporte de Membrana/farmacología , Modelos Moleculares , Estructura Molecular , Proteínas Asociadas a Resistencia a Múltiples Medicamentos/química , Proteínas Asociadas a Resistencia a Múltiples Medicamentos/fisiologíaRESUMEN
BACKGROUND: The goal of this study was to investigate whether exogenous offer of L-arginine (LARG) modulates the gene expression of intestinal dysfunction caused by ischemia and reperfusion. METHODS: Eighteen Wistar-EPM1 male rats (250-300 g) were anesthetized and subjected to laparotomy. The superior mesenteric vessels were exposed, and the rats were randomized into 3 groups (n = 6): the control group (CG), with no superior mesenteric artery interruption; the ischemia/reperfusion group (IRG), with 60 minutes of ischemia and 120 minutes of reperfusion and saline injections; and the L-arginine group (IRG + LARG), with L-arginine injected in the femoral vein 5 minutes before ischemia, 5 minutes after reperfusion, and after 55 minutes of reperfusion. The total RNA was extracted and purified from samples of the small intestine. The concentration of each total RNA sample was determined by using spectrophotometry. The first-strand complementary DNA (cDNA) was synthesized in equal amounts of cDNA and the Master Mix SYBR Green qPCR Mastermix (SABiosciences, a Qiagen Company, Frederick, Md). Amounts of cDNA and Master Mix SYBR Green qPCR Mastermix were distributed to each well of the polymerase chain reaction microarray plate containing the predispensed gene-specific primer sets for Bax and Bcl2. Each sample was evaluated in triplicate, and the Student t test was applied to validate the homogeneity of each gene expression reaction (P < .05). RESULTS: The gene expression of Bax in IRG (+1.48) was significantly higher than in IRG-LARG (+9.69); the expression of Bcl2L1 in IRG (+1.01) was significantly higher than IRG-LARG (+22.89). CONCLUSIONS: The apoptotic cell pathway of 2 protagonists showed that LARG improves the gene expression of anti-apoptotic Bcl2l1 (Bcl2-like 1) more than the pro-apoptotic Bax (Bcl2-associated X protein).
Asunto(s)
Arginina/farmacología , Intestino Delgado/irrigación sanguínea , Intestino Delgado/metabolismo , Isquemia/metabolismo , Daño por Reperfusión/metabolismo , Proteína X Asociada a bcl-2/metabolismo , Animales , Apoptosis , Intestino Delgado/patología , Isquemia/complicaciones , Isquemia/patología , Masculino , Arteria Mesentérica Superior , ARN Mensajero/genética , ARN Mensajero/metabolismo , Distribución Aleatoria , Ratas , Ratas Wistar , Daño por Reperfusión/etiología , Daño por Reperfusión/patología , Proteína X Asociada a bcl-2/genéticaRESUMEN
The effect on memory processes of inactivation of the M1 gene by an antisense oligodeoxyribonucleotide (aODN) was investigated in the mouse passive avoidance test. Mice received a single intracerebroventricular (i.c.v.) injection of M1 aODN (0.3, 1.0 or 2.0 nmol per injection), degenerated ODN (dODN) or vehicle on days 1, 4 and 7. An amnesic effect, comparable to that produced by antimuscarinic drugs, was observed 12, 24, 48 and 72 h after the last i.c.v. aODN injection, whereas dODN and vehicle, used as controls, did not produce any effect. Reduction in the entrance latency to the dark compartment induced by aODN disappeared 7 days after the end of aODN treatment, which indicates the absence of any irreversible damage or toxicity caused by aODN. Quantitative reverse transcription-polymerase chain reaction analysis demonstrated that a decrease in M1 mRNA levels occurred only in the aODN-treated group, being absent in all control groups. Furthermore, a reduction in M1 receptors was observed in the hippocampus of aODN-treated mice. Neither aODN, dODN nor vehicle produced any behavioral impairment of mice. These results indicate that the integrity and functionality of M1 receptors are fundamental in the modulation of memory processes.
Asunto(s)
Amnesia/fisiopatología , Reacción de Prevención/efectos de los fármacos , Ventrículos Cerebrales/fisiología , Memoria/fisiología , Oligodesoxirribonucleótidos Antisentido/farmacología , Receptores Muscarínicos/genética , Amnesia/inducido químicamente , Animales , Membrana Celular/metabolismo , Corteza Cerebral/efectos de los fármacos , Corteza Cerebral/metabolismo , Ventrículos Cerebrales/efectos de los fármacos , Hipocampo/efectos de los fármacos , Hipocampo/metabolismo , Inyecciones Intraventriculares , Masculino , Memoria/efectos de los fármacos , Ratones , Antagonistas Muscarínicos/farmacología , Oligodesoxirribonucleótidos Antisentido/administración & dosificación , Pirenzepina/análogos & derivados , Pirenzepina/metabolismo , ARN Mensajero/genética , Tiempo de Reacción , Receptor Muscarínico M1 , Receptores Muscarínicos/fisiología , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Factores de Tiempo , Transcripción Genética/efectos de los fármacosRESUMEN
R-(+)-hyoscyamine, the dextro enantiomer of atropine, has been shown to amplify cholinergic transmission. R-(+)-hyoscyamine, unlike S-(-)-hyoscyamine, was able to increase acetylcholine release both in vitro and in vivo at a range of concentrations (10(-14) to 10(-12) M) and doses (5 microg/kg i.p.) which were inadequate for blocking muscarinic receptors. The increase over control values in ACh release was 15.9 +/- 2.1% in in vitro experiments performed in rat phrenic nerve-hemidiaphragm preparations (n = 6), and 63.3 + 16.3% in cortical microdialysis performed in free-moving rats (n = 5). The maximum ACh release was reached 60 min after R-(+)-hyoscyamine administration in in vivo experiments. At the same doses and concentrations, R-(+)-hyoscyamine was also able to elicit: antinociception of a cholinergic type (55.6-112.7% depending on the test used); complete prevention of scopolamine- and dicyclomine-induced amnesia; potentiation of muscular contractions electrically evoked in isolated guinea-pig ileum (16.7 +/- 3.6%) and in rat phrenic nerve-hemidiaphragm (19.9 +/- 3.2%) preparations. Antinociception was performed using the hot-plate and acetic acid abdominal constriction tests in mice, and the paw pressure test in rats, while prevention of induced amnesia was evaluated in mice using the passive-avoidance test. The respective affinities (pA2) for R-(+)- and S-(-)-hyoscyamine vs M1 (rabbit vas deferens), M2 (rat atrium) and M3 (rat ileum) receptor subtypes were as follows: 7.05 +/- 0.05/9.33 +/- 0.03 for M1; 7.25 +/- 0.04/8.95 +/- 0.01 for M2; 6.88 +/- 0.05/9.04 +/- 0.03 for M3. The respective pKi values for R-(+)- and S-(-)-hyoscyamine vs the five human muscarinic receptor subtypes expressed in Chinese hamster oocytes (CHO-K1) were as follows: 8.21 +/- 0.07/9.48 +/- 0.18 for m1; 7.89 +/- 0.06/9.45 +/- 0.31 for m2; 8.06 +/- 0.18/9.30 +/- 0.19 for m3; 8.35 +/- 0.11/9.55 +/- 0.13 for m4; 8.17 +/- 0.08/9.24 +/- 0.30 for m5.
Asunto(s)
Atropina/farmacología , Fibras Colinérgicas/efectos de los fármacos , Transmisión Sináptica/efectos de los fármacos , Animales , Relación Dosis-Respuesta a Droga , Cobayas , Masculino , Ratones , Conejos , Ratas , Ratas Wistar , EstereoisomerismoRESUMEN
The enantiomers of three chiral muscarinic antagonists carrying a 1,3-oxathiolane nucleus were prepared and their absolute configuration established. The enantioselectivity and tissue selectivity of such compounds were studied on rat bladder and guinea pig ileum and heart. The results show that introduction of a sulfoxide function brings about a small but definite enantioselectivity in the 1,3-oxathiolane compound (2), which in itself does not show enantioselectivity among the tissues studied. The results obtained point to differences among cardiac and ileal muscarinic receptors. Comparison of the absolute configuration related agonists shows that the most potent isomers of both series share the same absolute stereochemistry.
Asunto(s)
Ciclohexanos/farmacología , Compuestos Heterocíclicos/farmacología , Muscarina/antagonistas & inhibidores , Tiofenos , Animales , Función Atrial , Carbacol/farmacología , Fenómenos Químicos , Química , Ciclohexanos/síntesis química , Cobayas , Frecuencia Cardíaca/efectos de los fármacos , Compuestos Heterocíclicos/síntesis química , Íleon/fisiología , Conformación Molecular , Contracción Muscular/efectos de los fármacos , Contracción Miocárdica/efectos de los fármacos , Ratas , Receptores Muscarínicos/efectos de los fármacos , Receptores Muscarínicos/fisiología , Estereoisomerismo , Relación Estructura-Actividad , Vejiga Urinaria/fisiologíaRESUMEN
The four isomers of 2-cyclohexyl-2-phenyl-5-[(dimethylamino)methyl] -1,3-oxathiolane methiodide were prepared. Their absolute configuration was attributed by means of X-ray crystallography and circular dichroism. The compounds were tested on rat bladder and guinea pig ileum and heart, and their antimuscarinic potency was evaluated and expressed as pA2. The results show that the introduction of a chiral center into position 2 brings about a small but definite enantioselectivity on rat bladder and guinea pig ileum which is not seen for guinea pig heart. This supports the view that differences exist among the muscarinic receptors of these tissues (M2 receptors). Comparison of the absolute configuration of the antagonists studied in this and in the preceding paper2 and that of strictly related agonists supports the hypothesis of a common binding site for agonists and antagonists of this kind.
Asunto(s)
Ciclohexanos/farmacología , Compuestos Heterocíclicos/farmacología , Muscarina/antagonistas & inhibidores , Tiofenos , Animales , Función Atrial , Fenómenos Químicos , Química , Ciclohexanos/síntesis química , Cobayas , Frecuencia Cardíaca/efectos de los fármacos , Compuestos Heterocíclicos/síntesis química , Íleon/fisiología , Conformación Molecular , Contracción Muscular/efectos de los fármacos , Contracción Miocárdica/efectos de los fármacos , Ratas , Receptores Muscarínicos/efectos de los fármacos , Receptores Muscarínicos/fisiología , Estereoisomerismo , Relación Estructura-Actividad , Vejiga Urinaria/fisiologíaRESUMEN
A number of fluorenyl and diphenylmethane analogues of verapamil, chosen as having the same substituents arranged in different ways around the quaternary carbon, were synthesized in order to evaluate the importance of the stereoisomerism at that point of the molecule. The compounds were tested with the Langendorff technique and coronary perfusion pressure (CPP), left ventricular pressure (LVP), and heart rate (HR) were recorded. While most of the compounds were almost inactive on these parameters, three of them did show interesting cardiovascular action. In particular they produced a more pronounced decrease in CPP than verapamil, with a less marked negative inotropic effect. Structure-activity relationships and the mechanism of action of the compounds are discussed.
Asunto(s)
Bloqueadores de los Canales de Calcio , Verapamilo/análogos & derivados , Animales , Bloqueadores de los Canales de Calcio/síntesis química , Sistema Cardiovascular/efectos de los fármacos , Fenómenos Químicos , Química , Cobayas , Frecuencia Cardíaca/efectos de los fármacos , Masculino , Contracción Miocárdica/efectos de los fármacos , Conejos , Relación Estructura-Actividad , Verapamilo/síntesis química , Verapamilo/farmacologíaRESUMEN
As a continuation of previous studies on chiral cholinergic agonists carrying a 1,3-oxathiolane nucleus, the enantiomers of c-2-methyl-r-5-[(dimethylamino)methyl]-1,3-oxathiolane t-3-oxide methiodide ((+)- and (-)-1) and of cis-2-methyl-5-[(dimethylamino)methyl]-1,3-oxathiolane 3,3-dioxide ((+)- and (-)-2) were obtained and their absolute configurations established by synthesis. The cholinergic potency of the four isomers was evaluated in vitro on guinea pig ileum and frog rectus abdominis models, and the results show that (-)-1, which has the same absolute configuration as L-(+)-muscarine, is a selective and potent muscarinic agent. The (+)-1 enantiomer is some hundred times less potent than (-)-1 on the muscarinic guinea pig ileum while, on the same tissue, the corresponding sulfone derivatives ((+)- and (-)-2) show no enantioselectivity.
Asunto(s)
Dimetilaminas , Compuestos Heterocíclicos , Receptores Colinérgicos/metabolismo , Sulfonas/metabolismo , Tiofenos , Animales , Dicroismo Circular , Dimetilaminas/metabolismo , Cobayas , Compuestos Heterocíclicos/metabolismo , Receptores Muscarínicos/metabolismo , EstereoisomerismoRESUMEN
The eight isomers of 2-cyclohexyl-2-phenyl-5-[(dimethylamino)methyl]-1, 3-oxathiolane 3-oxide methiodides were prepared and their absolute configurations were attributed by synthesis and by X-ray crystallography. The compounds were tested on guinea pig bladder, ileum, and heart and their antimuscarinic potency was evaluated and expressed as pA2. The absolute configuration of the most potent isomer [(+)-(2R,3R,5R)-7] is identical with that of the corresponding agonist [(2R,3R,5R)-c-2-methyl-r-5-[(dimethylamino)methyl]-1,3-oxathiolane t-e-oxide methiodide],3 which further supports our previous hypothesis that muscarinic agonists and antagonists of this series recognize a common binding site. While some of the racemates (3,4) show different enantioselectivity on the different tissues, the most potent and the most enantioselective one (7) does not discriminate between muscarinic receptors as it shows eudismic ratios of the same order for all tissues examined.
Asunto(s)
Ciclohexanos/síntesis química , Compuestos Heterocíclicos/síntesis química , Contracción Muscular/efectos de los fármacos , Músculo Liso/fisiología , Contracción Miocárdica/efectos de los fármacos , Parasimpatolíticos/síntesis química , Animales , Función Atrial , Ciclohexanos/farmacología , Cobayas , Atrios Cardíacos/efectos de los fármacos , Compuestos Heterocíclicos/farmacología , Íleon/efectos de los fármacos , Íleon/fisiología , Técnicas In Vitro , Indicadores y Reactivos , Isomerismo , Contracción Isométrica/efectos de los fármacos , Masculino , Conformación Molecular , Estructura Molecular , Músculo Liso/efectos de los fármacos , Relación Estructura-Actividad , Vejiga Urinaria/efectos de los fármacos , Vejiga Urinaria/fisiologíaRESUMEN
Three analogues with restricted flexibility were designed to study the active conformation of verapamil during interaction with the slow calcium channel. Thus cis- and trans-1-(3,4-dimethoxyphenyl)-4-[N-[2-(3,4-dimethoxy-phenyl)ethyl]-N- methylamino]-r-1-cyclohexanecarbonitrile (5a and 5b), and 4-(3,4-dimethoxyphenyl)-N-[2-(3,4-dimethoxyphenyl)ethyl]-4-cyanopiper idine, in which the verapamil structure is inserted into a cyclohexane or piperidine ring, were synthesized. Conformational analysis was performed with NMR and theoretical methods, and slow calcium channel antagonism was tested on guinea pig aorta strips. The compounds are some 100 times less potent than the parent compound even if they are able to reach conformations that are quite close to the lowest energy conformation proposed for verapamil and similar compounds. It appears that the flexibility to rotate around the bond between the quaternary atom and the adjacent methylene, a property which is lost in compounds 5a, 5b, and 6, is a major requisite for the calcium antagonism of verapamil.
Asunto(s)
Bloqueadores de los Canales de Calcio/síntesis química , Verapamilo/análogos & derivados , Animales , Bloqueadores de los Canales de Calcio/farmacología , Fenómenos Químicos , Química , Cobayas , Conformación Molecular , Contracción Muscular/efectos de los fármacos , Músculo Liso Vascular/efectos de los fármacos , Estereoisomerismo , Relación Estructura-Actividad , Verapamilo/químicaRESUMEN
The potent cholinergic agonist (+/-)-cis-2-methyl-5-[(dimethylamino)methyl]-1,3-oxathiolane methiodide (+/-)-1] was resolved into enantiomeric forms. Their absolute configurations were established by a synthetic pathway that also allowed the synthesis of the corresponding diastereomeric (+)- and (-)-trans-2-methyl-5-[(dimethylamino)-methyl]-1,3-oxathiolane methiodide [(+)- and (-)-10]. Compound (+)-1, which is the most potent of the four isomers, showed the same absolute configuration as L-(+)-muscarine and (+)-cis-dioxolane. The four isomers were tested on guinea pig ileum and frog rectus abdominis, and their muscarinic and nicotinic potency (EPMR) and selectivity were determined. The relationships between stereoisomerism and potency are discussed.
Asunto(s)
Dimetilaminas/farmacología , Compuestos Heterocíclicos/farmacología , Receptores Colinérgicos/fisiología , Tiofenos , Animales , Anuros , Cobayas , Masculino , Muscarina/farmacología , Contracción Muscular/efectos de los fármacos , Músculo Liso/fisiología , Receptores Colinérgicos/efectos de los fármacos , Receptores Muscarínicos/efectos de los fármacos , Receptores Muscarínicos/fisiología , Receptores Nicotínicos/efectos de los fármacos , Receptores Nicotínicos/fisiología , EstereoisomerismoRESUMEN
Several 4-substituted 1-acylpiperazines, obtained by molecular simplification of 4-substituted 1,4-diazabicyclo[4.3.0]nonan-9-ones, have been synthesized and tested in vivo on the mouse passive avoidance test, to evaluate their nootropic activity. The results show that, apparently, an N-acylpiperazine group can mimic the 2-pyrrolidinone ring of 1,4-diazabicyclo[4.3.0]nonan-9-one, as the compounds of the new series maintain high nootropic activity. Moreover molecular simplification produces more clear-cut structure-activity relationships with respect to the parent series. The mechanism of action also appears to be similar in the two series. In fact, although the molecular mechanism remains to be elucidated, the most potent compound of each class (DM232 and 13, DM235) is able to increase acetylcholine release in rat brain. Piperazine derivatives represent a new class of nootropic drugs with an in vivo pharmacological profile very similar to that of piracetam, showing much higher potency with respect to the reference compound. Among the compounds studied, 13 (DM235) shows outstanding potency, being active at a dose of 0.001 mg kg(-1) sc.
Asunto(s)
Compuestos Bicíclicos Heterocíclicos con Puentes/química , Nootrópicos/síntesis química , Piperazinas/síntesis química , Acetilcolina/metabolismo , Analgésicos/síntesis química , Analgésicos/química , Analgésicos/farmacología , Animales , Reacción de Prevención/efectos de los fármacos , Masculino , Memoria/efectos de los fármacos , Ratones , Microdiálisis , Nootrópicos/química , Nootrópicos/farmacología , Lóbulo Parietal/metabolismo , Piperazinas/química , Piperazinas/farmacología , Ratas , Ratas Wistar , Conducta Social , Relación Estructura-ActividadRESUMEN
DMPP is a well-known nicotinic agonist that does not fit any proposed pharmacophore for nicotinic binding and represents a unique ligand among the hundreds of nicotinic agonists studied in the past decades. A systematic modulation of the chemical structure of DMPP, aimed to establish its structure-affinity relationships, is reported. The research has allowed to identify molecules such as 11c, 13c, 14c, and 28c, with affinities for alpha(4)beta(2) receptors in the low nanomolar range, some 2 orders of magnitude lower than the lead compound. The agonistic properties of the most interesting compounds have been assessed by measuring their analgesic activity on mice (hot-plate test). Another result of the research was the identification of DMPP analogues, such as 3a (K(i) = 90 nM) and 14b (K(i) = 180 nM), that maintain affinity for the central nicotinic receptor when the ammonium function is changed into an aminic one and are therefore possible leads for drug development in neurodegenerative diseases.
Asunto(s)
Yoduro de Dimetilfenilpiperazina/análogos & derivados , Yoduro de Dimetilfenilpiperazina/síntesis química , Agonistas Nicotínicos/síntesis química , Piperidinas/síntesis química , Piridinas/síntesis química , Receptores Nicotínicos/metabolismo , Analgésicos/síntesis química , Analgésicos/química , Analgésicos/farmacología , Animales , Corteza Cerebral/metabolismo , Yoduro de Dimetilfenilpiperazina/química , Yoduro de Dimetilfenilpiperazina/farmacología , Técnicas In Vitro , Ligandos , Masculino , Ratones , Agonistas Nicotínicos/química , Agonistas Nicotínicos/farmacología , Dimensión del Dolor , Piperidinas/química , Piperidinas/farmacología , Piridinas/química , Piridinas/farmacología , Ensayo de Unión Radioligante , Ratas , Ratas Wistar , Relación Estructura-ActividadRESUMEN
Previous studies have shown that (R)-(+)-hyoscyamine has analgesic activity as a consequence of increased ACh release following antagonism of central muscarinic autoreceptors. Since the enhancement of central cholinergic transmission could be beneficial for cognitive disorders, we manipulated (R)-(+)-hyoscyamine, synthesizing several derivatives of tropic and 2-phenylpropionic acids, with the aim of obtaining drugs which are able to increase ACh release and consequently to show analgesic and nootropic activities. The results showed that several new compounds are indeed potent analgesics (with an analgesic efficacy comparable to that of morphine) and that the most potent one ((+/-)-19, PG9) also has remarkable cognition-enhancing properties. Our study confirmed that the mechanism of action involves ACh release even if it is still unclear whether only muscarinic autoreceptors or, also, heteroreceptors are involved.
Asunto(s)
Acetilcolina/metabolismo , Analgésicos/síntesis química , Cognición/efectos de los fármacos , Fenilpropionatos/síntesis química , Sinapsis/fisiología , Tropanos/síntesis química , Analgesia , Analgésicos/farmacología , Animales , Reacción de Prevención/efectos de los fármacos , Ratones , Estructura Molecular , Antagonistas Muscarínicos , Fenilpropionatos/farmacología , Receptores Muscarínicos/fisiología , Estereoisomerismo , Relación Estructura-Actividad , Sinapsis/efectos de los fármacos , Tropanos/farmacologíaRESUMEN
Further modifications of the leads ((R)-(+)-hyoscyamine and (p-chlorophenyl)propionic acid alpha-tropanyl ester), which show analgesic and nootropic activities as a consequence of increased central presynaptic ACh release, are reported. 2-Phenoxy- and 2-(phenylthio)alkanoic acid esters showed the best results. Several members of these classes possess analgesic properties which are comparable to that of morphine and at the same time are able to reverse dicyclomine-induced amnesia. Confirmation was found that the mechanism of action is due to an increase in ACh release at central muscarinic synapses and that both auto- and heteroreceptors controlling ACh release are very likely involved. According to the results obtained with (R)-(+)-hyoscyamine, analgesic activity is stereochemistry dependent, since the R-(+)-enantiomers are always more efficacious than the corresponding S-(-)-ones. On the basis of their potency and acute toxicity, compounds (+/-)-28 (SM21) and (+/-)-42 (SM32) were selected for further study.
Asunto(s)
Acetatos/síntesis química , Acetilcolina/metabolismo , Analgésicos/síntesis química , Cognición/efectos de los fármacos , Propionatos/síntesis química , Sinapsis/fisiología , Tropanos/síntesis química , Acetatos/farmacología , Analgesia , Analgésicos/farmacología , Animales , Ratones , Estructura Molecular , Propionatos/farmacología , Estereoisomerismo , Relación Estructura-Actividad , Sinapsis/efectos de los fármacos , Tropanos/farmacologíaRESUMEN
Several 4-substituted 1,4-diazabicyclo[4.3.0]nonan-9-ones have been synthesized and tested in vivo on mouse passive avoidance test, to evaluate their nootropic activity. The results show that they represent a new class of nootropic drugs with a pharmacological profile very similar to that of piracetam, showing much higher potency with respect to the reference. Among the compounds studied, 7 (DM 232) shows outstanding potency, being active at the dose of 0. 001 mg kg(-1) sc.
Asunto(s)
Diseño de Fármacos , Nootrópicos/síntesis química , Nootrópicos/farmacología , Piperazinas/síntesis química , Piperazinas/farmacología , Pirroles/síntesis química , Pirroles/farmacología , Agonistas alfa-Adrenérgicos , Amnesia/inducido químicamente , Amnesia/tratamiento farmacológico , Amnesia/prevención & control , Animales , Reacción de Prevención/efectos de los fármacos , Baclofeno , Clonidina , Relación Dosis-Respuesta a Droga , Agonistas del GABA , Mecamilamina , Ratones , Estructura Molecular , Antagonistas Muscarínicos , Nicotina/antagonistas & inhibidores , Piperazinas/uso terapéutico , Piracetam/farmacología , Pirroles/uso terapéutico , EscopolaminaRESUMEN
On the basis of the results obtained in previous research, three series of compounds (A-C), derived from verapamil, were designed and synthesized to obtain drugs able to revert multidrug resistance (MDR), an acquired resistance that frequently impairs cancer chemotherapy. The ability of the obtained compounds to revert MDR was evaluated on anthracycline-resistant erythroleukemia K 562 cells, measuring the uptake of THP-adriamycin (pirarubicin) by continuous spectrofluorometric monitoring of the decrease of the fluorescence signal of the anthracycline at 590 nm (lambdaex = 480 nm), after incubation with cells. Cardiovascular activity, which is responsible for unwanted side effects, was also evaluated. The results obtained show that many of the compounds studied are potent reverters of MDR and are endowed with reduced cardiovascular activity. One of the compounds (7, MM36) presents a pharmacological profile (unprecedented nanomolar potency, high reversal of MDR, low cardiovascular activity) that makes it a promising drug candidate to treat MDR and a useful tool for studying P-glycoprotein.
Asunto(s)
Anisoles/síntesis química , Antineoplásicos/síntesis química , Nitrilos/síntesis química , Animales , Anisoles/química , Anisoles/farmacología , Anisoles/toxicidad , Antineoplásicos/química , Antineoplásicos/farmacología , Antineoplásicos/toxicidad , Aorta/efectos de los fármacos , Aorta/fisiología , Diseño de Fármacos , Resistencia a Múltiples Medicamentos , Resistencia a Antineoplásicos , Ensayos de Selección de Medicamentos Antitumorales , Frecuencia Cardíaca/efectos de los fármacos , Humanos , Técnicas In Vitro , Contracción Muscular/efectos de los fármacos , Músculo Liso Vascular/efectos de los fármacos , Músculo Liso Vascular/fisiología , Nitrilos/química , Nitrilos/farmacología , Nitrilos/toxicidad , Conejos , Relación Estructura-Actividad , Células Tumorales CultivadasRESUMEN
The synthesis and pharmacological activities of the four isomeric racemates of alpha-[1-[3-[N-[1-[2-(3,4-dimethoxyphenyl)ethyl]]-N- methylamino]cyclohexyl]]-alpha-isopropyl-3,4-dimethoxybenzene-acetoni trile are reported (2a-d). The compounds are verapamil analogues with restricted molecular flexibility designed to gather information on the active conformation(s) of the parent drug. The relative stereochemistry of the four racemates was established by X-ray crystallography and by 1H NMR spectroscopy; conformational analysis was supported by theoretical calculations. Negative inotropic and chronotropic activities were evaluated on guinea pig atria, while vasodilatory activity on smooth muscle was tested on guinea pig aortic strips. Binding studies on cat ventricles were performed using (-)-[N-methyl-3H]desmethoxyverapamil (D888) as a reference ligand. The results seem to support the hypothesis that cardiac depressant and vasorelaxant activities are due to different conformations of the verapamil molecule.